A bitter taste has always been considered a warning signal, devoted to protecting us from ingesting potentially harmful ...

A bitter taste has always been considered a warning signal, devoted to protecting us from ingesting potentially harmful substances. But bitter taste ...

Scientists are closing in on a goal that once sounded like science fiction: triggering the benefits of a workout inside bone ...

Baseline Therapeutics, Inc. (baseline-tx.com) is a San Francisco-based clinical-stage biotechnology company developing breakthrough therapeutics for addiction. Baseline's lead program, BT-001, is a ...

Roche reports positive phase II results for its dual GLP-1/GIP receptor agonist CT-388 in people living with obesity: Basel Wednesday, January 28, 2026, 10:00 Hrs [IST] Roche anno ...

While fragrances can be approached from an artistic standpoint, some perfumers have started using scientific research to ...

Nugevia™ supports metabolic, mitochondrial, and neuroinflammatory biology impacted by GLP-1-driven weight lossJupiter, Florida, Jan. 28, 2026 ...

The field of metabolic disease therapeutics has experienced rapid advancement with the introduction of glucagon-like peptide-1 receptor agonists (GLP-1RAs), ...

GLP-1 medications were designed to curb hunger. Instead, they may be muting the brain’s deepest cravings — forcing a rethink of how biology, not willpower, governs appetite, impulse and even addiction ...

Nugevia supports metabolic, mitochondrial, and neuroinflammatory biology impacted by GLP-1-driven weight loss Jupiter, Florida, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: ...

A biomarker blood panel that incorporates four different proteins-ANPEP, PIGR, CA19-9, and THBS2-enhanced the detection of pancreatic ductal ...

In A Nutshell Living detectors: Researchers modified E. coli bacteria to light up when they sense acetic acid, the chemical ...